1Edward J. Wawrzynczak,Graham J. Watson,Alan J. Cumber,Raymond V. Henry,Geoffrey D. Parnell,E. Peter Rieber,Philip E. Thorpe. Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin[J] 1991,Cancer Immunology Immunotherapy(5):289～295
2Hnatowich DJ,Virzi F,Rusckowski M.Investigatioins of avidin and biotin for imaging application[].The Journal of Nuclear Medicine.1987
3Rosebrough SF,Iadicicco RA,Englehart JK.Quantitation, pharmacokinetics and analysis of biotin, avidin and streptavidin in vivo[].The Journal of Nuclear Medicine.1991
4Paganelli G,Malcovati M,Fazio F.Monoclonal antibody pretargeting techniques for tumour localization: the avidin-biotin system[].Nuclear Medicine Communications.1991
5Hnatowich DJ,Childs RL,Lanteigne D,et al.The preparation of DTPAcoupled antibodies radiolabeled with metallic radionuclides: an improved method[].Journal of Immunological Methods.1983
6Rusckowski M,Fogarasi M,Fritz B,et al.Effect of endogenous biotin on the applications of streptavidin and biotin in mice[].Nuclear Medicine and Biology.1997
1Rosenblum M G, Marks J W, Cheung L H. Comparative cytotoxicity and pharmacokinetics of antimelanoma immunotoxins containing either natural or recombinant gelonin[J].Cancer Chemother Pharmacol, 1999, 44(4):343-8.
2Liu Y Y, Gordienko I, Mathias A, et al. Express of an anti-CD3 single-chain immuneotoxin with a truncated diphtheria toxin in a mutant CHO cell line [J] .Protein Expr Purif, 2000, 19(2) :304-11.
3Vallera D A, Burns L J, Frankel A E, et al. Laboratory preparation of a deglycosylated ricin toxin A chain containing immunotoxin directed against a CD7 T lineage differentiation antigen for phase I human clinical studies involving T cell malignancies[J] .J Immunoll Methods, 1996, 197(1-2): 69-83.
4Woo B H, Lee J T, Na D H, et al. Sepharose-unbinding ricin E as a source for ricin A chain immunotoxin [J]. J Immunol Methods, 2001,249(1-2):91-8.
5Schlick J L, Dulieu P, Desvoyes B, et al. Cytotoxic activity of a recombinant GnRH-PAP fusion toxin on human tumor cell lines [J]. FEBS Letters, 2000, 472 (2-3): 241-6.
